nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadobenate Dimeglumine—Localised oedema—Hydrochlorothiazide—nephrolithiasis	0.0624	0.0676	CcSEcCtD
Gadobenate Dimeglumine—Feeling cold—Hydrochlorothiazide—nephrolithiasis	0.0552	0.0597	CcSEcCtD
Gadobenate Dimeglumine—Cardiac murmur—Hydrochlorothiazide—nephrolithiasis	0.0509	0.0551	CcSEcCtD
Gadobenate Dimeglumine—Atrioventricular block complete—Hydrochlorothiazide—nephrolithiasis	0.0451	0.0488	CcSEcCtD
Gadobenate Dimeglumine—ALB—Scavenging of heme from plasma—AMBP—nephrolithiasis	0.0329	0.435	CbGpPWpGaD
Gadobenate Dimeglumine—Sinus bradycardia—Hydrochlorothiazide—nephrolithiasis	0.0322	0.0348	CcSEcCtD
Gadobenate Dimeglumine—Hyperlipidaemia—Hydrochlorothiazide—nephrolithiasis	0.0219	0.0237	CcSEcCtD
Gadobenate Dimeglumine—Ventricular arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.0213	0.0231	CcSEcCtD
Gadobenate Dimeglumine—Feeling hot—Hydrochlorothiazide—nephrolithiasis	0.0201	0.0217	CcSEcCtD
Gadobenate Dimeglumine—Glycosuria—Hydrochlorothiazide—nephrolithiasis	0.0195	0.0211	CcSEcCtD
Gadobenate Dimeglumine—Gamma-glutamyltransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0192	0.0207	CcSEcCtD
Gadobenate Dimeglumine—Hyperkalaemia—Hydrochlorothiazide—nephrolithiasis	0.0155	0.0168	CcSEcCtD
Gadobenate Dimeglumine—Wheezing—Hydrochlorothiazide—nephrolithiasis	0.0153	0.0166	CcSEcCtD
Gadobenate Dimeglumine—Blood urea increased—Hydrochlorothiazide—nephrolithiasis	0.0149	0.0161	CcSEcCtD
Gadobenate Dimeglumine—Ecchymosis—Hydrochlorothiazide—nephrolithiasis	0.0143	0.0154	CcSEcCtD
Gadobenate Dimeglumine—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.014	0.0152	CcSEcCtD
Gadobenate Dimeglumine—ALB—Binding and Uptake of Ligands by Scavenger Receptors—AMBP—nephrolithiasis	0.0131	0.173	CbGpPWpGaD
Gadobenate Dimeglumine—Swelling—Hydrochlorothiazide—nephrolithiasis	0.013	0.014	CcSEcCtD
Gadobenate Dimeglumine—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.0121	0.0131	CcSEcCtD
Gadobenate Dimeglumine—Thirst—Hydrochlorothiazide—nephrolithiasis	0.012	0.013	CcSEcCtD
Gadobenate Dimeglumine—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.0115	0.0124	CcSEcCtD
Gadobenate Dimeglumine—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.0115	0.0124	CcSEcCtD
Gadobenate Dimeglumine—Migraine—Hydrochlorothiazide—nephrolithiasis	0.0113	0.0122	CcSEcCtD
Gadobenate Dimeglumine—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.0111	0.012	CcSEcCtD
Gadobenate Dimeglumine—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.0107	0.0116	CcSEcCtD
Gadobenate Dimeglumine—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.0106	0.0114	CcSEcCtD
Gadobenate Dimeglumine—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0112	CcSEcCtD
Gadobenate Dimeglumine—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0109	CcSEcCtD
Gadobenate Dimeglumine—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00914	0.00989	CcSEcCtD
Gadobenate Dimeglumine—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.00893	0.00966	CcSEcCtD
Gadobenate Dimeglumine—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.00867	0.00939	CcSEcCtD
Gadobenate Dimeglumine—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00858	0.00928	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00858	0.00928	CcSEcCtD
Gadobenate Dimeglumine—Sweating—Hydrochlorothiazide—nephrolithiasis	0.00846	0.00915	CcSEcCtD
Gadobenate Dimeglumine—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00841	0.0091	CcSEcCtD
Gadobenate Dimeglumine—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00806	0.00873	CcSEcCtD
Gadobenate Dimeglumine—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00794	0.00859	CcSEcCtD
Gadobenate Dimeglumine—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00788	0.00853	CcSEcCtD
Gadobenate Dimeglumine—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.0078	0.00844	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00763	0.00826	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00739	0.00799	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00735	0.00795	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00708	0.00766	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Hydrochlorothiazide—nephrolithiasis	0.0069	0.00746	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00675	0.00731	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00667	0.00722	CcSEcCtD
Gadobenate Dimeglumine—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00663	0.00717	CcSEcCtD
Gadobenate Dimeglumine—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00646	0.00699	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.0064	0.00692	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00637	0.0069	CcSEcCtD
Gadobenate Dimeglumine—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.0063	0.00682	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00622	0.00673	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00618	0.00669	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00617	0.00668	CcSEcCtD
Gadobenate Dimeglumine—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00609	0.00659	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00606	0.00656	CcSEcCtD
Gadobenate Dimeglumine—Cough—Hydrochlorothiazide—nephrolithiasis	0.00602	0.00651	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00587	0.00635	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00587	0.00635	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00587	0.00635	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00585	0.00633	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.0058	0.00628	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00574	0.00621	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00567	0.00614	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00563	0.00609	CcSEcCtD
Gadobenate Dimeglumine—Shock—Hydrochlorothiazide—nephrolithiasis	0.00554	0.00599	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00549	0.00594	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00544	0.00589	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00526	0.00569	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00513	0.00555	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00505	0.00547	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00502	0.00543	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.005	0.00541	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00495	0.00536	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00485	0.00525	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00481	0.00521	CcSEcCtD
Gadobenate Dimeglumine—Pain—Hydrochlorothiazide—nephrolithiasis	0.00481	0.00521	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00464	0.00502	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.0046	0.00498	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00447	0.00484	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00445	0.00481	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00445	0.00481	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00415	0.00449	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00404	0.00437	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00398	0.00431	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00385	0.00417	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00372	0.00403	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00358	0.00387	CcSEcCtD
Gadobenate Dimeglumine—Rash—Hydrochlorothiazide—nephrolithiasis	0.00355	0.00384	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00355	0.00384	CcSEcCtD
Gadobenate Dimeglumine—Headache—Hydrochlorothiazide—nephrolithiasis	0.00353	0.00381	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00334	0.00362	CcSEcCtD
Gadobenate Dimeglumine—ALB—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00227	0.03	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00208	0.0274	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00208	0.0274	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00158	0.0208	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00158	0.0208	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.00149	0.0196	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00146	0.0193	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00146	0.0193	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00131	0.0172	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.0013	0.0171	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.0013	0.0171	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00115	0.0152	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00106	0.0139	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00106	0.0139	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.0008	0.0106	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.0008	0.0106	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—SLC7A9—nephrolithiasis	0.000766	0.0101	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—DGKH—nephrolithiasis	0.000766	0.0101	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000744	0.00982	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000744	0.00982	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000663	0.00876	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000663	0.00876	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00053	0.007	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GRHPR—nephrolithiasis	0.00046	0.00607	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—AGXT—nephrolithiasis	0.00041	0.00541	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—APRT—nephrolithiasis	0.000349	0.0046	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—SLC26A1—nephrolithiasis	0.000349	0.0046	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—AQP1—nephrolithiasis	0.000248	0.00328	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CHRM3—nephrolithiasis	0.000225	0.00296	CbGpPWpGaD
